» Articles » PMID: 37408215

Conversion of Unmodified Stem Cells to Pacemaker Cells by Overexpression of Key Developmental Genes

Overview
Journal Cells
Publisher MDPI
Date 2023 Jul 6
PMID 37408215
Authors
Affiliations
Soon will be listed here.
Abstract

Arrhythmias of the heart are currently treated by implanting electronic pacemakers and defibrillators. Unmodified adipose tissue-derived stem cells (ASCs) have the potential to differentiate into all three germ layers but have not yet been tested for the generation of pacemaker and Purkinje cells. We investigated if-based on overexpression of dominant conduction cell-specific genes in ASCs-biological pacemaker cells could be induced. Here we show that by overexpression of certain genes that are active during the natural development of the conduction system, the differentiation of ASCs to pacemaker and Purkinje-like cells is feasible. Our study revealed that the most effective procedure consisted of short-term upregulation of gene combinations SHOX2-TBX5-HCN2, and to a lesser extent SHOX2-TBX3-HCN2. Single-gene expression protocols were ineffective. Future clinical implantation of such pacemaker and Purkinje cells, derived from unmodified ASCs of the same patient, could open up new horizons for the treatment of arrythmias.

Citing Articles

Pacemaker Channels and the Chronotropic Response in Health and Disease.

Hennis K, Piantoni C, Biel M, Fenske S, Wahl-Schott C Circ Res. 2024; 134(10):1348-1378.

PMID: 38723033 PMC: 11081487. DOI: 10.1161/CIRCRESAHA.123.323250.


Application of adipose-derived stem cells in ischemic heart disease: theory, potency, and advantage.

Xiao W, Shi J Front Cardiovasc Med. 2024; 11:1324447.

PMID: 38312236 PMC: 10834651. DOI: 10.3389/fcvm.2024.1324447.

References
1.
Yang M, Zhao Q, Zhao H, Yang A, Wang F, Wang X . Adipose‑derived stem cells overexpressing SK4 calcium‑activated potassium channel generate biological pacemakers. Int J Mol Med. 2019; 44(6):2103-2112. PMC: 6844603. DOI: 10.3892/ijmm.2019.4374. View

2.
Ben-David U, Benvenisty N . The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer. 2011; 11(4):268-77. DOI: 10.1038/nrc3034. View

3.
Yu H, Lu K, Zhu J, Wang J . Stem cell therapy for ischemic heart diseases. Br Med Bull. 2017; 121(1):135-154. DOI: 10.1093/bmb/ldw059. View

4.
Ieda M, Fu J, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau B . Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010; 142(3):375-86. PMC: 2919844. DOI: 10.1016/j.cell.2010.07.002. View

5.
Saito Y, Nakamura K, Yoshida M, Sugiyama H, Akagi S, Miyoshi T . Enhancement of pacing function by HCN4 overexpression in human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther. 2022; 13(1):141. PMC: 8973792. DOI: 10.1186/s13287-022-02818-y. View